Literature DB >> 20860351

Selective binding of antiinfluenza drugs and their analogues to 'open' and 'closed' conformations of H5N1 neuraminidase.

Pei Wang1, John Z H Zhang.   

Abstract

It was suggested that the open conformation of the 150-loop of H5N1 avian influenza neuraminidase is intrinsically lower in energy than the closed conformation and that oseltamivir (tamiflu) favors binding to the closed conformation through a relatively slow conformational change [Russell, R. J. Nature 2006, 443, 45-49]. In the present work, a systematic computational study is performed to investigate the binding mechanism of five ligands to H5N1 neuraminidase (H5N1 NA) with the 150-loop in both open and closed conformations through molecular docking, molecular dynamics simulations, and MM/PBSA free energy calculation. Our result shows that the electrostatic interactions between polar groups on the 150-loop and the charged groups of the ligands play a key role on the binding selectivity. In particular, ligands having a small positively charged group favor binding to the closed conformation of H5N1 NA, while those having a large positively charged group generally prefer binding to the open conformation. Our analysis suggests that it may be possible to design new inhibitors with large basic groups that are selective for the open conformation and thereby have stronger binding affinity to H5N1 neuraminidase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20860351     DOI: 10.1021/jp1030224

Source DB:  PubMed          Journal:  J Phys Chem B        ISSN: 1520-5207            Impact factor:   2.991


  6 in total

1.  Discovery of Influenza A virus neuraminidase inhibitors using support vector machine and Naïve Bayesian models.

Authors:  Wenwen Lian; Jiansong Fang; Chao Li; Xiaocong Pang; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2015-12-21       Impact factor: 2.943

2.  The significance of naturally occurring neuraminidase quasispecies of H5N1 avian influenza virus on resistance to oseltamivir: a point of concern.

Authors:  Nalini Schaduangrat; Jiraphorn Phanich; Thanyada Rungrotmongkol; Hatairat Lerdsamran; Pilaipan Puthavathana; Sukathida Ubol
Journal:  J Gen Virol       Date:  2016-03-02       Impact factor: 3.891

3.  Molecular-level simulation of pandemic influenza glycoproteins.

Authors:  Rommie E Amaro; Wilfred W Li
Journal:  Methods Mol Biol       Date:  2012

4.  Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase.

Authors:  Gema L Ramírez-Salinas; J García-Machorro; Miguel Quiliano; Mirko Zimic; Verónica Briz; Saul Rojas-Hernández; J Correa-Basurto
Journal:  J Mol Model       Date:  2015-10-26       Impact factor: 1.810

5.  Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition.

Authors:  Christopher J Vavricka; Qing Li; Yan Wu; Jianxun Qi; Mingyang Wang; Yue Liu; Feng Gao; Jun Liu; Enguang Feng; Jianhua He; Jinfang Wang; Hong Liu; Hualiang Jiang; George F Gao
Journal:  PLoS Pathog       Date:  2011-10-20       Impact factor: 6.823

6.  Five Novel Non-Sialic Acid-Like Scaffolds Inhibit In Vitro H1N1 and H5N2 Neuraminidase Activity of Influenza a Virus.

Authors:  Luis Márquez-Domínguez; Julio Reyes-Leyva; Irma Herrera-Camacho; Gerardo Santos-López; Thomas Scior
Journal:  Molecules       Date:  2020-09-16       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.